State Claims Reinstated In Novartis Elidel FCA Suit

Law360, New York (November 5, 2013, 2:16 PM EST) -- The federal judge overseeing a former Novartis Pharmaceuticals Corp. employee’s whistleblower lawsuit accusing the drugmaker of ripping off Medicaid by promoting off-label uses of eczema treatment Elidel on Tuesday reinstated some claims she had previously dismissed.

Citing her own “clear error,” U.S. District Judge Gene E.K. Pratter partially granted relator Donald Galmines’ motion for reconsideration of his June dismissal of Louisiana and Massachusetts claims, but declined to reconsider claims under California and Washington, D.C., law.

“While the court has supplemental jurisdiction over all the claims, the...
To view the full article, register now.